Melanoma clinical data and biocollections platform
Design, validate or accelerate clinical development with expert infrastructures.
Offer overview
What this offer helps you achieve
Design, validate or accelerate clinical development with expert infrastructures.
Scientific and technical scope
MELBASE a national cohort of patients with unresectable stage IIb, III and IV melanoma treated in France, linked to biological ressources and multimodal data coordinated by Céleste Lebbé
Capabilities mobilised
Therapeutic areasExpert adviceClinical validationReal-life monitoringBiotesting
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
